AI assistant
Tarsus Pharmaceuticals, Inc. — Director's Dealing 2021
Jun 18, 2021
31511_dirs_2021-06-17_67c79a3f-c29d-4157-a28f-15c59b1f12d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tarsus Pharmaceuticals, Inc. (TARS)
CIK: 0001819790
Period of Report: 2021-06-15
Reporting Person: Ackermann Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-15 | Common Stock | A | 4257 | $0.00 | Acquired | 1233181 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Stock Option (right to buy) | $35.26 | A | 10000 | Acquired | 2031-06-15 | Common Stock (10000) | Direct |
| 2021-06-15 | Stock Option (right to buy) | $35.26 | A | 10000 | Acquired | 2031-06-15 | Common Stock (10000) | Direct |
| 2021-06-15 | Restricted Stock Units | $ | A | 4257 | Acquired | Common Stock (4257) | Direct |
Footnotes
F1: The Reporting Person was granted restricted stock units ("RSUs") in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The RSUs are fully vested as of the date of grant.
F2: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
F3: Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested.
F4: Each RSU represents a contingent right to receive one share of the Company's common stock.
F5: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.